大麻二酚对视觉功能和车辆驾驶性能影响的随机交叉实验。

IF 5.2 1区 医学 Q1 PSYCHIATRY
Addiction Pub Date : 2025-01-06 DOI:10.1111/add.16746
Sonia Ortiz-Peregrina, Francesco Martino, Miriam Casares-López, Pilar Granados-Delgado, Rosario G Anera, José J Castro Torres
{"title":"大麻二酚对视觉功能和车辆驾驶性能影响的随机交叉实验。","authors":"Sonia Ortiz-Peregrina, Francesco Martino, Miriam Casares-López, Pilar Granados-Delgado, Rosario G Anera, José J Castro Torres","doi":"10.1111/add.16746","DOIUrl":null,"url":null,"abstract":"<p><strong>Aims: </strong>This study aimed to determine the effect of vaporized cannabidiol (CBD) on visual function and vehicle driving performance, given the growing popularity of CBD use worldwide.</p><p><strong>Design: </strong>Randomized, double-blind, placebo-controlled cross-over experimental study.</p><p><strong>Setting: </strong>Laboratory of Vision Sciences and Applications, University of Granada, Spain.</p><p><strong>Participants: </strong>Thirty participants were recruited through advertisements placed in the local newspaper and distributed among the university community. They had a mean age of 26.2 (6.2) years, and 70% were male. All of them were occasional users of CBD or cannabis, and held valid driving licenses.</p><p><strong>Interventions: </strong>Three experimental sessions, conducted one week apart, in which a placebo, 15% CBD (16 mg) or 30% CBD (32 mg) was vaporized.</p><p><strong>Measurements: </strong>The primary endpoint for driving performance was the overall driving performance score (ODPS). Secondary outcomes included visual function variables such as static and dynamic visual acuity, stereoacuity, contrast sensitivity, motion detection and other driving performance parameters such as mean speed, lateral vehicle control or reaction time.</p><p><strong>Findings: </strong>Comparisons revealed no statistically significant changes in ODPS after vaporizing CBD at 15% or 30% compared with the placebo (χ<sup>2</sup> = 0.479; P = 0.787). Visual function remained largely unchanged, with only a statistically significant decrease in motion detection (χ<sup>2</sup> = 7.980; P = 0.018). Similarly, no statistically significant differences were found in driving performance secondary outcomes, such as the standard deviation of lateral lane position (χ<sup>2</sup> = 0.068; P = 0.966), distance travelled outside the lane (χ<sup>2</sup> = 2.530; P = 0.282), reaction time (χ<sup>2</sup> = 1.000; P = 0.607), or collisions (χ<sup>2</sup> = 0.987; P = 0.610). Additionally, correlations between ODPS and visual function did not yield statistically significant results.</p><p><strong>Conclusions: </strong>Consumption of vaporized cannabidiol in 16 mg and 32 mg doses does not appear to affect simulated vehicle driving performance and visual function.</p>","PeriodicalId":109,"journal":{"name":"Addiction","volume":" ","pages":""},"PeriodicalIF":5.2000,"publicationDate":"2025-01-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Visual function and vehicle driving performance under the effects of cannabidiol: A randomized cross-over experiment.\",\"authors\":\"Sonia Ortiz-Peregrina, Francesco Martino, Miriam Casares-López, Pilar Granados-Delgado, Rosario G Anera, José J Castro Torres\",\"doi\":\"10.1111/add.16746\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Aims: </strong>This study aimed to determine the effect of vaporized cannabidiol (CBD) on visual function and vehicle driving performance, given the growing popularity of CBD use worldwide.</p><p><strong>Design: </strong>Randomized, double-blind, placebo-controlled cross-over experimental study.</p><p><strong>Setting: </strong>Laboratory of Vision Sciences and Applications, University of Granada, Spain.</p><p><strong>Participants: </strong>Thirty participants were recruited through advertisements placed in the local newspaper and distributed among the university community. They had a mean age of 26.2 (6.2) years, and 70% were male. All of them were occasional users of CBD or cannabis, and held valid driving licenses.</p><p><strong>Interventions: </strong>Three experimental sessions, conducted one week apart, in which a placebo, 15% CBD (16 mg) or 30% CBD (32 mg) was vaporized.</p><p><strong>Measurements: </strong>The primary endpoint for driving performance was the overall driving performance score (ODPS). Secondary outcomes included visual function variables such as static and dynamic visual acuity, stereoacuity, contrast sensitivity, motion detection and other driving performance parameters such as mean speed, lateral vehicle control or reaction time.</p><p><strong>Findings: </strong>Comparisons revealed no statistically significant changes in ODPS after vaporizing CBD at 15% or 30% compared with the placebo (χ<sup>2</sup> = 0.479; P = 0.787). Visual function remained largely unchanged, with only a statistically significant decrease in motion detection (χ<sup>2</sup> = 7.980; P = 0.018). Similarly, no statistically significant differences were found in driving performance secondary outcomes, such as the standard deviation of lateral lane position (χ<sup>2</sup> = 0.068; P = 0.966), distance travelled outside the lane (χ<sup>2</sup> = 2.530; P = 0.282), reaction time (χ<sup>2</sup> = 1.000; P = 0.607), or collisions (χ<sup>2</sup> = 0.987; P = 0.610). Additionally, correlations between ODPS and visual function did not yield statistically significant results.</p><p><strong>Conclusions: </strong>Consumption of vaporized cannabidiol in 16 mg and 32 mg doses does not appear to affect simulated vehicle driving performance and visual function.</p>\",\"PeriodicalId\":109,\"journal\":{\"name\":\"Addiction\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":5.2000,\"publicationDate\":\"2025-01-06\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Addiction\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1111/add.16746\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"PSYCHIATRY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Addiction","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/add.16746","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PSYCHIATRY","Score":null,"Total":0}
引用次数: 0

摘要

目的:本研究旨在确定汽化大麻二酚(CBD)对视觉功能和车辆驾驶性能的影响,鉴于CBD在全球范围内的使用日益普及。设计:随机、双盲、安慰剂对照交叉实验研究。单位:西班牙格拉纳达大学视觉科学与应用实验室。参与者:30名参与者通过刊登在当地报纸上的广告招募,并在大学社区中分发。他们的平均年龄为26.2(6.2)岁,70%为男性。他们都偶尔吸食CBD或大麻,并持有有效的驾驶执照。干预措施:三个实验阶段,间隔一周进行,其中安慰剂、15% CBD(16毫克)或30% CBD(32毫克)被蒸发。测量:驾驶表现的主要终点是总体驾驶表现得分(ODPS)。次要结果包括视觉功能变量,如静态和动态视敏度、立体视敏度、对比灵敏度、运动检测和其他驾驶性能参数,如平均速度、横向车辆控制或反应时间。结果:比较显示,与安慰剂相比,15%或30% CBD汽化后ODPS无统计学意义变化(χ2 = 0.479;p = 0.787)。视觉功能基本保持不变,仅运动检测功能下降有统计学意义(χ2 = 7.980;p = 0.018)。同样,驾驶性能次要指标,如侧车道位置标准差,也无统计学差异(χ2 = 0.068;P = 0.966)、车道外行驶距离(χ2 = 2.530;P = 0.282)、反应时间(χ2 = 1.000;P = 0.607)或碰撞(χ2 = 0.987;p = 0.610)。此外,ODPS和视觉功能之间的相关性没有产生统计学上显著的结果。结论:16 mg和32 mg剂量的汽化大麻二酚似乎不会影响模拟车辆的驾驶性能和视觉功能。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Visual function and vehicle driving performance under the effects of cannabidiol: A randomized cross-over experiment.

Aims: This study aimed to determine the effect of vaporized cannabidiol (CBD) on visual function and vehicle driving performance, given the growing popularity of CBD use worldwide.

Design: Randomized, double-blind, placebo-controlled cross-over experimental study.

Setting: Laboratory of Vision Sciences and Applications, University of Granada, Spain.

Participants: Thirty participants were recruited through advertisements placed in the local newspaper and distributed among the university community. They had a mean age of 26.2 (6.2) years, and 70% were male. All of them were occasional users of CBD or cannabis, and held valid driving licenses.

Interventions: Three experimental sessions, conducted one week apart, in which a placebo, 15% CBD (16 mg) or 30% CBD (32 mg) was vaporized.

Measurements: The primary endpoint for driving performance was the overall driving performance score (ODPS). Secondary outcomes included visual function variables such as static and dynamic visual acuity, stereoacuity, contrast sensitivity, motion detection and other driving performance parameters such as mean speed, lateral vehicle control or reaction time.

Findings: Comparisons revealed no statistically significant changes in ODPS after vaporizing CBD at 15% or 30% compared with the placebo (χ2 = 0.479; P = 0.787). Visual function remained largely unchanged, with only a statistically significant decrease in motion detection (χ2 = 7.980; P = 0.018). Similarly, no statistically significant differences were found in driving performance secondary outcomes, such as the standard deviation of lateral lane position (χ2 = 0.068; P = 0.966), distance travelled outside the lane (χ2 = 2.530; P = 0.282), reaction time (χ2 = 1.000; P = 0.607), or collisions (χ2 = 0.987; P = 0.610). Additionally, correlations between ODPS and visual function did not yield statistically significant results.

Conclusions: Consumption of vaporized cannabidiol in 16 mg and 32 mg doses does not appear to affect simulated vehicle driving performance and visual function.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Addiction
Addiction 医学-精神病学
CiteScore
10.80
自引率
6.70%
发文量
319
审稿时长
3 months
期刊介绍: Addiction publishes peer-reviewed research reports on pharmacological and behavioural addictions, bringing together research conducted within many different disciplines. Its goal is to serve international and interdisciplinary scientific and clinical communication, to strengthen links between science and policy, and to stimulate and enhance the quality of debate. We seek submissions that are not only technically competent but are also original and contain information or ideas of fresh interest to our international readership. We seek to serve low- and middle-income (LAMI) countries as well as more economically developed countries. Addiction’s scope spans human experimental, epidemiological, social science, historical, clinical and policy research relating to addiction, primarily but not exclusively in the areas of psychoactive substance use and/or gambling. In addition to original research, the journal features editorials, commentaries, reviews, letters, and book reviews.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信